We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$230M
AUM Growth
-$12.3M
Cap. Flow
-$21.2M
Cap. Flow %
-9.21%
Top 10 Hldgs %
41.59%
Holding
122
New
32
Increased
19
Reduced
29
Closed
19

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$2.41M
2
GM icon
General Motors
GM
+$2.39M
3
ABBV icon
AbbVie
ABBV
+$2.25M
4
CVS icon
CVS Health
CVS
+$1.57M
5
LLY icon
Eli Lilly
LLY
+$1.03M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$3.11M
2
INTC icon
Intel
INTC
+$2.44M
3
GILD icon
Gilead Sciences
GILD
+$1.84M
4
XLNX
Xilinx Inc
XLNX
+$1.67M
5
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$1.53M

Sector Composition

Rank Sector Weight
1 Healthcare 35.26%
2 Technology 14.96%
3 Communication Services 9.7%
4 Financials 5.34%
5 Consumer Discretionary 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AYX
76
DELISTED
Alteryx Inc
AYX
$550K 0.24%
6,625
+625
+10% +$66.2K
PFE icon
77
Pfizer
PFE
$143B
$543K 0.24%
+15,000
New +$533K
NVDA icon
78
NVIDIA
NVDA
$4.86T
$534K 0.23%
+40,000
New +$538K
ESPR
79
DELISTED
Esperion Therapeutics
ESPR
$485K 0.21%
17,286
-21,214
-55% -$626K
QTNT
80
DELISTED
Quotient Limited Ordinary Shares
QTNT
$484K 0.21%
+3,288
New +$650K
OVID icon
81
Ovid Therapeutics
OVID
$414M
$438K 0.19%
+109,001
New +$362K
MTNB icon
82
Matinas BioPharma
MTNB
$1.88M
$420K 0.18%
8,000
+1,894
+31% +$127K
APTX
83
DELISTED
Aptinyx Inc. Common Stock
APTX
$390K 0.17%
130,000
-1,000
-0.8% -$3.59K
FXI icon
84
CALL
iShares China Large-Cap ETF
FXI
$4.37B
$373K 0.16%
+8,000
New +$397K
VIR icon
85
Vir Biotechnology
VIR
$1.46B
$369K 0.16%
7,192
-13,808
-66% -$744K
ARNA
86
DELISTED
Arena Pharmaceuticals Inc
ARNA
$347K 0.15%
5,000
-1,000
-17% -$77K
FCX icon
87
Freeport-McMoran
FCX
$90B
$329K 0.14%
10,000
-10,000
-50% -$324K
GMAB icon
88
Genmab
GMAB
$17.7B
$328K 0.14%
10,000
– –
GILD icon
89
CALL
Gilead Sciences
GILD
$162B
$323K 0.14%
+5,000
New +$322K
TBHC
90
DELISTED
The Brand House Collective
TBHC
$295K 0.13%
10,500
-250
-2% -$6.24K
TDC icon
91
Teradata
TDC
$2.92B
$289K 0.13%
7,500
-35,000
-82% -$1.28M
BOX icon
92
CALL
Box
BOX
$4.37B
$287K 0.12%
+12,500
New +$243K
CRM icon
93
Salesforce
CRM
$151B
$265K 0.12%
1,250
+250
+25% +$55.7K
F icon
94
CALL
Ford
F
$58.5B
$245K 0.11%
+20,000
New +$229K
NVDA icon
95
CALL
NVIDIA
NVDA
$4.86T
$214K 0.09%
+16,000
New +$215K
TBT icon
96
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
$207K 0.09%
+9,500
New +$184K
UVXY icon
97
CALL
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$224M
$206K 0.09%
+15
New +$351K
SGMO
98
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$175K 0.08%
14,000
– –
ADT icon
99
ADT
ADT
$5.58B
$118K 0.05%
+14,000
New +$121K
OBSV
100
DELISTED
ObsEva SA Ordinary Shares
OBSV
$86K 0.04%
26,500
-23,500
-47% -$82.9K
1 2 3
4
5

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, DCF Advisers held 122 positions worth $230M, down 5.1% from $242M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

DCF Advisers withdrew a net $21.2M in Q1 2021, closing 19 positions and reducing 29 holdings. Its most notable exit was Intel, an estimated $2.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 32% a quarter earlier, followed by Technology and Communication Services.

Against the trend, DCF Advisers opened a new position in CVS Health worth $1.62M.

  • DCF Advisers's largest Q1 2021 buy was CVS Health: 21,500 shares worth $1.62M.
  • DCF Advisers added most to Verizon in Q1 2021, an estimated $2.41M increase.
  • DCF Advisers's biggest Q1 2021 reduction was SPDR Gold Trust, cutting an estimated $3.11M.
  • DCF Advisers fully exited Intel in Q1 2021, selling an estimated $2.44M.
  • DCF Advisers's ten largest holdings make up 42% of its $230M portfolio in Q1 2021.
  • DCF Advisers opened 32 new positions and closed 19 in Q1 2021.
  • DCF Advisers's portfolio value fell 5.1% quarter-over-quarter to $230M.

Based on DCF Advisers's 13F filing for Q1 2021, filed 12 May 2021.